Advertising disclosure: we may earn a commission when you buy through links on this site. How we make money

HomeTrials › NCT07575399

Obesity & weight · Phase 3 · Recruiting now

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

NCT07575399 · Sponsor: Amgen

What this trial means for you

This study is recruiting now at 39 US sites. It's studying Maridebart Cafraglutide for obesity or overweight.

Who can joinAll sexes, 18 Years – 99 Years
Healthy volunteersNo — diagnosis required
What you'd takeMaridebart Cafraglutide
Study length~20 months overall
Planned participants300
TypeInterventional (you receive treatment)

What participants typically get: study medication (or placebo, if the trial uses one) and study-related medical care at no cost, plus close monitoring. Compensation for time and travel varies by study — ask the site. Note that in many trials you can't choose your treatment group, and some participants receive a placebo.

The study, in the sponsor's words

Efficacy, safety and tolerability of switching from GLP-1RA to maridebart cafraglutide in adults with obesity or overweight.

Can you join? The exact criteria

Below is the verbatim eligibility text from the registry — bring it to your doctor; it's written for clinicians, and your own clinician is the right person to interpret it with you.

Full eligibility criteria (for you and your doctor)

Inclusion Criteria: * Body Mass Index (BMI) ≥ 25 at screening. * Weight loss of ≥ 10% on weekly GLP-1 RA. * Stable body weight. * Stable dose of GLP-1RA. * Stable gastrointestinal (GI) tolerability. * Contraception for females. * Willingness to follow trial procedures for the duration of the trial. Exclusion Criteria: * Obesity induced by other endocrine disorders (ex: Cushing's syndrome). * Previous or planned surgical, endoscopic or device-based treatment for obesity. * History of malignancy. * Type 1/Type 2 diabetes mellitus (DM). * Family or personal history of medullary thyroid cancer. * Previous participation in a Maridebart Cafraglutide trial.

Study sites by state

Alabama

  • Cahaba Research, Inc. — Pelham · Recruiting now

Arizona

  • Arizona Clinical Trials — Chandler · Recruiting now
  • Epic Medical Research - Sun City — Sun City · Recruiting now

California

  • Desert Oasis Healthcare Medical Group — Palm Springs · Recruiting now
  • Inland Empire Liver Foundation — Rialto · Recruiting now
  • Peninsula Research Associates — Rolling Hills Estates · Recruiting now
  • Apex Clinical Research — San Diego · Recruiting now
  • Southern California Clinical Research — Santa Ana · Recruiting now

Florida

  • Aga Clinical Trials — Hialeah · Recruiting now
  • South Florida Clinical Research — Margate · Recruiting now
  • New Horizon Research Center — Miami · Recruiting now
  • Research Institute of South Florida — Miami · Recruiting now
  • Clinical Neuroscience Solutions — Orlando · Recruiting now
  • Florida Institute for Clinical Research — Orlando · Recruiting now
  • Progressive Medical Research — Port Orange · Recruiting now
  • Charter Research - The Villages — The Villages · Recruiting now

Georgia

  • Nsc Research — Johns Creek · Recruiting now
  • Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group — Union City · Recruiting now
  • North Georgia Clinical Research — Woodstock · Recruiting now

Idaho

  • Solaris Clinical Research — Meridian · Recruiting now

Illinois

  • Endeavor Health — Skokie · Recruiting now

Michigan

  • Arcturus Healthcare, Public Limited Company, Troy Internal Medicine Research Division — Troy · Recruiting now

Mississippi

  • Sky Integrative Medical Center — Ridgeland · Recruiting now

Nevada

  • Excel Clinical Research — Las Vegas · Recruiting now

New York

  • Rochester Clinical Research — Rochester · Recruiting now

North Carolina

  • Centricity Research Morehead City Specialty — Morehead City · Recruiting now
  • Accellacare of Raleigh — Raleigh · Recruiting now
  • Accellacare Research of Wilmington — Wilmington · Recruiting now

Oklahoma

  • Lynn Health Science Institute — Oklahoma City · Recruiting now

Pennsylvania

  • Altoona Center for Clinical Research — Duncansville · Recruiting now

Texas

  • Epic Medical Research - DeSoto — DeSoto · Recruiting now
  • South Texas Research Institute — Edinburg · Recruiting now
  • Biopharma Informatic, LLC — Houston · Recruiting now
  • Research Physicians Network, LLC — Houston · Recruiting now
  • Texas Institute of Cardiology — McKinney · Recruiting now
  • North Hills Medical Research — North Richland Hills · Recruiting now
  • VIP Trials — San Antonio · Recruiting now
  • Northwest Houston Heart Center — Tomball · Recruiting now

Washington

  • Eastside Research Associates Health Research — Redmond · Recruiting now

View the official record on ClinicalTrials.gov →

Verify before you act. Medical disclaimer: content on this site is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs; always consult a licensed healthcare provider about eligibility, risks, and benefits. Trial details and enrollment status change frequently — always verify on the official registry and talk to your own clinician before contacting a study site. This page was generated from registry data and is not affiliated with the study sponsor.

Follow this trial

Get an email when our monthly digest covers enrollment changes and results for trials like this one.

Newsletter signup launches soon. (Site owner: set PUBLIC_BUTTONDOWN_USERNAME in .env to activate this form.)

Keep researching on StudyBackedHealth